Oppenheimer Upgrades AngioDynamics to Outperform, Announces $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Steven Lichtman upgraded AngioDynamics (NASDAQ:ANGO) from Perform to Outperform and set a $12 price target. This upgrade reflects a positive outlook on the company's future performance.
April 05, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AngioDynamics was upgraded by Oppenheimer from Perform to Outperform with a new price target of $12, indicating a positive future outlook.
Upgrades by reputable analysts like Steven Lichtman from Oppenheimer often lead to increased investor confidence and can drive the stock price up in the short term. The setting of a $12 price target suggests a significant upside potential from current levels, further fueling positive sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100